ArticleJGH open : an open access journal of gastroenterology and hepatology2022

Significance of post-progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.

Yoshihiko Yano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.